Valuation: PharmaEssentia Corporation

Market Cap 53TCr 1.65TCr 1.44TCr 1.33TCr 1.23TCr 2.33TCr 1,57400Cr 2.37TCr 16TCr 6.25TCr 78TCr 6.2TCr 6.06TCr 2,66600Cr P/E 2026 *
49.3x
P/E 2027 * 35.9x
Enterprise Value 50TCr 1.57TCr 1.37TCr 1.26TCr 1.17TCr 2.22TCr 1,49500Cr 2.25TCr 15TCr 5.94TCr 74TCr 5.89TCr 5.76TCr 2,53200Cr EV / Sales 2026 *
20.1x
EV / Sales 2027 * 14.3x
Free-Float
75.38%
Yield 2026 *
0.07%
Yield 2027 * 0.11%
1 day-6.84%
1 week+2.18%
Current month+6.37%
1 month+52.61%
3 months+120.65%
6 months+178.40%
Current year+203.28%
1 week 1,245
Extreme 1245
1,415.34
1 month 854.61
Extreme 854.6101
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - 01/08/2022
Director TitleAgeSince
Director/Board Member 78 01/03/2014
Director/Board Member 73 01/05/2024
Director/Board Member - 30/06/2006
Change 5-day change 1-year change 3-year change Capi.($)
-6.84%+2.18%+195.12%+357.18% 1.65TCr
+1.84%-0.66%+59.82%+92.96% 5.49TCr
-4.14%-8.06%+58.96%+118.67% 5.46TCr
-2.24%+3.59%+17.75%+477.47% 2.51TCr
-1.60%-6.21%-18.96%-15.21% 2.31TCr
+2.43%+1.06%+42.44%-1.27% 1.99TCr
-3.19%0.00%+35.60%-26.98% 1.75TCr
+8.74%+3.51%+51.91%+726.40% 1.57TCr
-1.05%+1.16%+25.95%+194.27% 1.42TCr
-4.16%+1.63%+70.13%+142.72% 1.24TCr
Average -1.02%-0.09%+53.87%+206.62% 2.54TCr
Weighted average by Cap. -1.05%-1.30%+52.18%+175.46%

Financials

2026 *2027 *
Net sales 2.51TCr 78Cr 68Cr 63Cr 58Cr 110.43Cr 7.45TCr 112.29Cr 752.92Cr 295.67Cr 3.67TCr 293.26Cr 286.88Cr 13TCr 3.46TCr 107.7Cr 94Cr 87Cr 80Cr 152.28Cr 10TCr 154.84Cr 1.04TCr 407.7Cr 5.06TCr 404.38Cr 395.58Cr 17TCr
Net income 1.09TCr 34Cr 30Cr 27Cr 25Cr 48Cr 3.23TCr 49Cr 326.01Cr 128.03Cr 1.59TCr 126.98Cr 124.22Cr 5.46TCr 1.5TCr 47Cr 41Cr 38Cr 35Cr 66Cr 4.45TCr 67Cr 449.67Cr 176.59Cr 2.19TCr 175.15Cr 171.33Cr 7.53TCr
Net Debt -2.65TCr -83Cr -72Cr -67Cr -62Cr -116.85Cr -7.88TCr -118.81Cr -796.66Cr -312.85Cr -3.88TCr -310.3Cr -303.55Cr -13TCr -3.47TCr -108.2Cr -95Cr -87Cr -81Cr -152.99Cr -10TCr -155.56Cr -1.04TCr -409.61Cr -5.08TCr -406.27Cr -397.43Cr -17TCr
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
09/26/09 NT$1,285.00 -6.84% 67,11,957
08/26/08 NT$1,379.28 +2.34% 47,71,223
07/26/07 NT$1,347.72 +3.46% 39,59,953
06/26/06 NT$1,302.65 +3.58% 29,09,866
03/26/03 NT$1,257.57 0.00% 35,56,029
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,285.00TWD
Average target price
1,057.48TWD
Spread / Average Target
-17.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock